abstract |
The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. Furthermore, the present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having formula (I), or a pharmaceutically acceptable salt, solvent or hydrate thereof. These compositions are useful in pharmaceutical compositions, and uses of the pharmaceutical compositions include the treatment of obesity. The selective 5HT-2C receptor agonist is (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine or a pharmaceutically acceptable salt, solvate thereof or It is a hydrate. |